https://fightcolorectalcancer.org/fight/treatment/
Post# of 148320
(Total Views: 493)
Posted On: 08/08/2019 6:29:12 AM
https://fightcolorectalcancer.org/fight/treat...ent-stage/
Treatments by stage
STAGE 0 AND STAGE I COLON CANCER
Patients diagnosed with stage 0 and stage I colon cancer are often cured by the surgery that removes the cancerous polyps or tumor.
STAGE 0 (IN SITU) COLON CANCER
Surgery is often the recommended treatment for stage 0 colon cancer.
Polypectomy — snaring and removing polyps containing cancer during a colonoscopy
Local excision — removal of flat colon growths “piecemeal” during colonoscopy
Open abdominal surgery — remove cancer, part of colon, and nearby lymph nodes in high risk situations
STAGE I COLON CANCER
For stage I colon cancer, surgery is also often the recommended treatment. It will typically be either:
Colectomy (resection) — removal of all or part of your colon through one incision
Laparoscopic colectomy — when a surgeon makes a few small incisions in your abdomen through which they pass a tiny camera and tools to access your colon
Medically reviewed by Dr. Al Benson, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 9/23/13
STAGE I RECTAL CANCER
There are a variety of different surgeries used to treat stage I rectal cancer:
Local excision through the anus
Low anterior resection (LAR) for tumors that are high enough in the rectum to permit reconnecting the colon or rectum to the anus (anastomosis)
Abdominoperineal resection with permanent colostomy when the distance between tumor and anus is too short to allow safe anastomosis
Possible Chemotherapy
If the tumor has gone through the outer layer of the rectum (T3) or there are cancer cells in lymph nodes (N1 or N2), then follow-up chemotherapy and chemoradiation may be recommended.
Possible Watch and Wait
For some stage I rectal cancers, there may be the option to watch and wait.
STAGE II COLON CANCER
Initial treatment for stage II colon cancer is surgery to remove the section of colon that contains the tumor and surrounding tissue with its blood vessels and lymph nodes. It could be either:
Open colectomy — when a surgeon makes a long incision in your abdomen so that they can access your colon
Laparoscopic colectomy — when a surgeon makes a few small incisions in your abdomen through which they pass a tiny camera and tools to access your colon
Chemotherapy
Treatment of node-negative stage II colon cancer is controversial. While surgery to remove the tumor in the colon is universally accepted as an initial treatment, the value of chemotherapy after that surgery (adjuvant chemotherapy) to keep cancer from recurring (coming back) is hard for patients and doctors to judge.
It’s estimated that between 4-5 percent of patients with stage II colon cancer will benefit from chemotherapy. However, there are side effects, some severe, associated with chemotherapy.
Clinical Trials
There are often clinical trials available for stage II colon cancer patients.
Medically reviewed by Dr. Al Benson, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 9/23/13
STAGE II RECTAL CANCER
For patients who are medically fit and able to undergo combined methods of therapy, treatment for stage II and III rectal cancer may consist of:
Chemoradiation before surgery
Abdominal surgery
Adjuvant chemotherapy
Patients with medical issues that make chemoradiation difficult may go directly to surgery, followed by:
No further treatment if their tumor hasn’t spread through the rectal wall or to lymph nodes
A reconsideration of adjuvant chemotherapy and chemoradiation if there is spread through the wall (T3) or into lymph nodes (N1 or N2)
STAGE III COLON CANCER
Most stage III colon cancer patients will receive a recommendation of surgery, colostomy, chemotherapy and possibly radiation.
Combination Chemotherapy
Patients who are able to tolerate combination chemotherapy that includes Eloxatin® are often prescribed:
Folfox — combination treatment with infusional 5-FU (fluorouracil), leucovorin, and oxaliplatin
Flox — combination with bolus 5-FU, leucovorin, and oxaliplatin. Severe diarrhea is more common with Flox than Folfox but outcomes are similar.
(“Bolus dose” is the administration of a medication that is given to raise its concentration in the blood to an effective level.)
Alternative Chemotherapy
Patients who have medical reasons not to use combination chemotherapy may be prescribed:
Xeloda® (capecitabine) — oral “prodrug” which is converted to 5-FU in the tissues
5-FU and leucovorin
Your doctor can discuss the advantages and disadvantages of the different chemotherapy regimens for your individual needs.
Radiation
If surgery reveals the tumor has spread outside the colon, follow-up radiation may be recommended. Radiation is not routine for stage III colon cancer.
Clinical Trials
There are often clinical trials available for stage III colon cancer.
STAGE III RECTAL CANCER
Most stage III rectal cancer patients will receive a recommendation of surgery, chemotherapy and chemoradiation combinations.
Surgery
For rectal cancer, abdominal surgery is often required to remove tumors. You may be treated with radiation and/or chemotherapy before surgery.
Low Anterior Resection (LAR)
Abdominoperineal Resection (APR)
Chemotherapy Combinations
For stage III rectal cancer patients who are medically fit and can tolerate combined methods of therapy, treatment can consist of chemoradiation (chemotherapy and radiation) before surgery (adjuvant therapy), abdominal surgery, and/or adjuvant chemotherapy after surgery.
Patients who cannot tolerate chemoradiation at first, may go directly to surgery with no additional treatment, and then onto adjuvant chemotherapy and/or chemoradiation after surgery.
For a list of chemoradiation options, adjuvant chemotherapy options, and adjuvant chemotherapy options (a “sandwich” of chemo-chemoradiation-chemo), download Your Guide in the Fight.
STAGE IV, METASTATIC CANCER OR RECURRENT CRC
Treatment for stage IV or recurrent colorectal cancer is complex, and generally requires consultation with medical, surgical and radiological doctors. For a list of questions to ask if you have stage IV or recurrent CRC, and for examples of treatment options combined to treat metastatic disease over time, download Your Guide in the Fight.
Take time to get the best information and advice possible from a multidisciplinary team. This process is vitally important. Make sure to get a second opinion, even if it takes extra time.
Surgery
If the liver, lungs, or the lining of the abdomen (peritoneum) are affected, you may undergo multiple surgeries to remove metastatic disease. Often, chemotherapy and radiation are combined with surgery to shrink tumors.
Partial Hepatectomy — also known as a liver resection, this surgery is intended to remove tumors from the liver
Pulmonary Metastasectomy — a surgery where tumors which have metastasized to the lung are removed
Chemoembolization Surgery — sometimes called transarterial chemoembolization (TACE), it is a combination of an embolization procedure (a procedure that reduces blood flow to the liver) and chemotherapy
Hyperthermic Intraperitoneal Chemotherapy — also called HIPEC, this surgery involves filling the abdominal cavity with heated chemotherapy drugs
Chemotherapy Combinations
There are a variety of chemotherapy combinations that may be prescribed.
Capox or Xelox — Capecitabine (Xeloda®) plus oxaliplatin (Eloxatin®). Capecitabine is an oral drug that works the same way as 5-FU inside the cancer cell.
Folfox — 5-FU, Oxaliplatin (Eloxatin®), and Leucovorin
Folfiri — 5-FU, Irinotecan (Camptosar®), and Leucovorin
These regimens may be combined with targeted therapies such as bevacizumab (Avastin®), cetuximab (Erbitux®), or panitumumab (Vectibix®).
Patients who are not able to tolerate intensive therapy have other options. Doctors may recommend:
5-FU plus leucovorin with or without bevacizumab (Avastin®)
Capecitabine (Xeloda®) with or without bevacizumab (Avastin®)
Treatment with capectiabine (Xeloda®) alone should only be considered a reasonable option for selected patients who are not candidates for more aggressive combination regimens with oxaliplatin (Eloxatin®) or irinotecan (Camptosar®).
Other Options
Patients who have stopped responding to other treatments or who cannot receive certain chemotherapy medicines have other options, like trifluridine and tipiracil (Lonsurf®), a nucleoside-analogue drug.
Targeted Therapies
There are approved targeted therapies for colorectal cancer, including:
Cetuximab (Erbitux®)
Panitumumab (Vectibix®)
Bevacizumab (Avastin®)
Ziv-aflibercept (Zaltrap®)
Regorafenib (Stivarga®)
Ramucirumab (Cyramza®)
Vemurafenib (Zelboraf ®)
Immunotherapies
Immunotherapy uses certain parts of a person’s immune system to fight disease. Immunotherapy for colorectal cancer has been shown to be effective in a small subset of patients with a certain biomarker, microsatellite-instability (MSI) or mismatch repair deficiency (MMR). All colorectal patients should know their MSI/MMR status!
Pembrolizumab (Keytruda ®)
This is an option for patients who have the microsatellite instable-high (MSI-H) or deficient mismatch repair (d-MMR) biomarkers. This treatment is indicated for adult and pediatric patients with unresectable or metastatic solid tumors that have been identified as having a MSI-H or dMMR biomarker, including patients with solid tumors that have progressed following prior treatment and who have no alternative treatment options.
Nivolumab (Opdivo ®)
This therapy is for use in microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC). Nivolumab has been approved for mCRC patients whose cancer either progressed after being treated with a fluoropyrimidine, oxaliplatin, and irinotecan, or did not respond to those treatments.
Ipilimumab (Yervoy®)
This drug may be used in combination with nivolumab as a treatment option for metastatic colorectal cancer (mCRC) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer following the progression on a fluoropyrimidine, oxaliplatin, and irinotecan.
Colorectal cancer treatment by stage can be straightforward in the early stages, but it can become incredibly complicated once the cancer progresses. Our Guide in the Fight includes more detailed colorectal cancer treatment by stage for stage III, IV and recurrent cancers.
Treatments by stage
STAGE 0 AND STAGE I COLON CANCER
Patients diagnosed with stage 0 and stage I colon cancer are often cured by the surgery that removes the cancerous polyps or tumor.
STAGE 0 (IN SITU) COLON CANCER
Surgery is often the recommended treatment for stage 0 colon cancer.
Polypectomy — snaring and removing polyps containing cancer during a colonoscopy
Local excision — removal of flat colon growths “piecemeal” during colonoscopy
Open abdominal surgery — remove cancer, part of colon, and nearby lymph nodes in high risk situations
STAGE I COLON CANCER
For stage I colon cancer, surgery is also often the recommended treatment. It will typically be either:
Colectomy (resection) — removal of all or part of your colon through one incision
Laparoscopic colectomy — when a surgeon makes a few small incisions in your abdomen through which they pass a tiny camera and tools to access your colon
Medically reviewed by Dr. Al Benson, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 9/23/13
STAGE I RECTAL CANCER
There are a variety of different surgeries used to treat stage I rectal cancer:
Local excision through the anus
Low anterior resection (LAR) for tumors that are high enough in the rectum to permit reconnecting the colon or rectum to the anus (anastomosis)
Abdominoperineal resection with permanent colostomy when the distance between tumor and anus is too short to allow safe anastomosis
Possible Chemotherapy
If the tumor has gone through the outer layer of the rectum (T3) or there are cancer cells in lymph nodes (N1 or N2), then follow-up chemotherapy and chemoradiation may be recommended.
Possible Watch and Wait
For some stage I rectal cancers, there may be the option to watch and wait.
STAGE II COLON CANCER
Initial treatment for stage II colon cancer is surgery to remove the section of colon that contains the tumor and surrounding tissue with its blood vessels and lymph nodes. It could be either:
Open colectomy — when a surgeon makes a long incision in your abdomen so that they can access your colon
Laparoscopic colectomy — when a surgeon makes a few small incisions in your abdomen through which they pass a tiny camera and tools to access your colon
Chemotherapy
Treatment of node-negative stage II colon cancer is controversial. While surgery to remove the tumor in the colon is universally accepted as an initial treatment, the value of chemotherapy after that surgery (adjuvant chemotherapy) to keep cancer from recurring (coming back) is hard for patients and doctors to judge.
It’s estimated that between 4-5 percent of patients with stage II colon cancer will benefit from chemotherapy. However, there are side effects, some severe, associated with chemotherapy.
Clinical Trials
There are often clinical trials available for stage II colon cancer patients.
Medically reviewed by Dr. Al Benson, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 9/23/13
STAGE II RECTAL CANCER
For patients who are medically fit and able to undergo combined methods of therapy, treatment for stage II and III rectal cancer may consist of:
Chemoradiation before surgery
Abdominal surgery
Adjuvant chemotherapy
Patients with medical issues that make chemoradiation difficult may go directly to surgery, followed by:
No further treatment if their tumor hasn’t spread through the rectal wall or to lymph nodes
A reconsideration of adjuvant chemotherapy and chemoradiation if there is spread through the wall (T3) or into lymph nodes (N1 or N2)
STAGE III COLON CANCER
Most stage III colon cancer patients will receive a recommendation of surgery, colostomy, chemotherapy and possibly radiation.
Combination Chemotherapy
Patients who are able to tolerate combination chemotherapy that includes Eloxatin® are often prescribed:
Folfox — combination treatment with infusional 5-FU (fluorouracil), leucovorin, and oxaliplatin
Flox — combination with bolus 5-FU, leucovorin, and oxaliplatin. Severe diarrhea is more common with Flox than Folfox but outcomes are similar.
(“Bolus dose” is the administration of a medication that is given to raise its concentration in the blood to an effective level.)
Alternative Chemotherapy
Patients who have medical reasons not to use combination chemotherapy may be prescribed:
Xeloda® (capecitabine) — oral “prodrug” which is converted to 5-FU in the tissues
5-FU and leucovorin
Your doctor can discuss the advantages and disadvantages of the different chemotherapy regimens for your individual needs.
Radiation
If surgery reveals the tumor has spread outside the colon, follow-up radiation may be recommended. Radiation is not routine for stage III colon cancer.
Clinical Trials
There are often clinical trials available for stage III colon cancer.
STAGE III RECTAL CANCER
Most stage III rectal cancer patients will receive a recommendation of surgery, chemotherapy and chemoradiation combinations.
Surgery
For rectal cancer, abdominal surgery is often required to remove tumors. You may be treated with radiation and/or chemotherapy before surgery.
Low Anterior Resection (LAR)
Abdominoperineal Resection (APR)
Chemotherapy Combinations
For stage III rectal cancer patients who are medically fit and can tolerate combined methods of therapy, treatment can consist of chemoradiation (chemotherapy and radiation) before surgery (adjuvant therapy), abdominal surgery, and/or adjuvant chemotherapy after surgery.
Patients who cannot tolerate chemoradiation at first, may go directly to surgery with no additional treatment, and then onto adjuvant chemotherapy and/or chemoradiation after surgery.
For a list of chemoradiation options, adjuvant chemotherapy options, and adjuvant chemotherapy options (a “sandwich” of chemo-chemoradiation-chemo), download Your Guide in the Fight.
STAGE IV, METASTATIC CANCER OR RECURRENT CRC
Treatment for stage IV or recurrent colorectal cancer is complex, and generally requires consultation with medical, surgical and radiological doctors. For a list of questions to ask if you have stage IV or recurrent CRC, and for examples of treatment options combined to treat metastatic disease over time, download Your Guide in the Fight.
Take time to get the best information and advice possible from a multidisciplinary team. This process is vitally important. Make sure to get a second opinion, even if it takes extra time.
Surgery
If the liver, lungs, or the lining of the abdomen (peritoneum) are affected, you may undergo multiple surgeries to remove metastatic disease. Often, chemotherapy and radiation are combined with surgery to shrink tumors.
Partial Hepatectomy — also known as a liver resection, this surgery is intended to remove tumors from the liver
Pulmonary Metastasectomy — a surgery where tumors which have metastasized to the lung are removed
Chemoembolization Surgery — sometimes called transarterial chemoembolization (TACE), it is a combination of an embolization procedure (a procedure that reduces blood flow to the liver) and chemotherapy
Hyperthermic Intraperitoneal Chemotherapy — also called HIPEC, this surgery involves filling the abdominal cavity with heated chemotherapy drugs
Chemotherapy Combinations
There are a variety of chemotherapy combinations that may be prescribed.
Capox or Xelox — Capecitabine (Xeloda®) plus oxaliplatin (Eloxatin®). Capecitabine is an oral drug that works the same way as 5-FU inside the cancer cell.
Folfox — 5-FU, Oxaliplatin (Eloxatin®), and Leucovorin
Folfiri — 5-FU, Irinotecan (Camptosar®), and Leucovorin
These regimens may be combined with targeted therapies such as bevacizumab (Avastin®), cetuximab (Erbitux®), or panitumumab (Vectibix®).
Patients who are not able to tolerate intensive therapy have other options. Doctors may recommend:
5-FU plus leucovorin with or without bevacizumab (Avastin®)
Capecitabine (Xeloda®) with or without bevacizumab (Avastin®)
Treatment with capectiabine (Xeloda®) alone should only be considered a reasonable option for selected patients who are not candidates for more aggressive combination regimens with oxaliplatin (Eloxatin®) or irinotecan (Camptosar®).
Other Options
Patients who have stopped responding to other treatments or who cannot receive certain chemotherapy medicines have other options, like trifluridine and tipiracil (Lonsurf®), a nucleoside-analogue drug.
Targeted Therapies
There are approved targeted therapies for colorectal cancer, including:
Cetuximab (Erbitux®)
Panitumumab (Vectibix®)
Bevacizumab (Avastin®)
Ziv-aflibercept (Zaltrap®)
Regorafenib (Stivarga®)
Ramucirumab (Cyramza®)
Vemurafenib (Zelboraf ®)
Immunotherapies
Immunotherapy uses certain parts of a person’s immune system to fight disease. Immunotherapy for colorectal cancer has been shown to be effective in a small subset of patients with a certain biomarker, microsatellite-instability (MSI) or mismatch repair deficiency (MMR). All colorectal patients should know their MSI/MMR status!
Pembrolizumab (Keytruda ®)
This is an option for patients who have the microsatellite instable-high (MSI-H) or deficient mismatch repair (d-MMR) biomarkers. This treatment is indicated for adult and pediatric patients with unresectable or metastatic solid tumors that have been identified as having a MSI-H or dMMR biomarker, including patients with solid tumors that have progressed following prior treatment and who have no alternative treatment options.
Nivolumab (Opdivo ®)
This therapy is for use in microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC). Nivolumab has been approved for mCRC patients whose cancer either progressed after being treated with a fluoropyrimidine, oxaliplatin, and irinotecan, or did not respond to those treatments.
Ipilimumab (Yervoy®)
This drug may be used in combination with nivolumab as a treatment option for metastatic colorectal cancer (mCRC) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer following the progression on a fluoropyrimidine, oxaliplatin, and irinotecan.
Colorectal cancer treatment by stage can be straightforward in the early stages, but it can become incredibly complicated once the cancer progresses. Our Guide in the Fight includes more detailed colorectal cancer treatment by stage for stage III, IV and recurrent cancers.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼